Not Yet Recruiting
NA
INTERVENTIONAL
NCT06863415
Study on the Enhancement of Intestinal and Immune Functions Through Probiotic Intervention
View on ClinicalTrials.gov
Updated Dec 15, 2025
Brief Summary
Evaluate the effectiveness and safety of Bifidobacterium longum subsp. infantis BI45 as a food supplement compared to a placebo in improving intestinal and immune functions in healthy adults.
Interventions
Name:
Probiotic
Type:
DIETARY_SUPPLEMENT
Description:
Dietary supplement: Probiotics. The trial period of this study lasts for 2 months (8 weeks), during which each participant will have 3 visits (at month 0, month 1, and month 2).
Name:
Placebo
Type:
DIETARY_SUPPLEMENT
Description:
Dietary supplement: Placebo. The trial period of this study lasts for 2 months (8 weeks), during which each participant will have 3 visits (at month 0, month 1, and month 2).
Primary Outcomes
Measure:
Change in the concentration of antimicrobial peptides (LL-37 and calprotectin) in feces before and after intervention
TimeFrame:
Week 0 and Week 8
Description:
Detected by Enzyme-Linked Immunosorbent Assay (ELISA).
Trial Information
NCT ID
NCT06863415
Status
Not Yet Recruiting
Study Type
INTERVENTIONAL
Phases
NA
Sponsor
Wecare Probiotics Co., Ltd.
Last Updated
December 15, 2025